Angela Zanfardino, Patrizia Bruzzi, Michela Trada, Novella Rapini, Emanuela Laudani, Gianluca Tornese, Federica Ortolani, Gianluca Piccolo, Lorena Matonti, Maria Alessandra Saltarelli, Tiziana Timpanaro, Giuseppe D'Annunzio, Barbara Predieri, Francesca Rossi, Rossella Mura, Veronica Barat, Arcangelo Prete, Riccardo Schiaffini, Stefano Zucchini
Glycemic abnormalities are a frequent finding in pediatric oncological patients, both during treatment and after its discontinuation. Moreover, impaired glucose tolerance (IGT), impaired fasting glycemia (IFG) and diabetes mellitus (DM) are not rarely diagnosed in non-oncological hematological diseases. To explore the current pediatric Italian approach to the diagnosis and the management of the glycemic alterations in this clinical setting and, thus, to identify and enforce current clinical needs, we submitted an online 23-items survey to all the Italian Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) centers, and surveys were descriptively analyzed...
April 2024: Pediatric Hematology and Oncology